Cargando…
The small molecule WNT/β-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway
BACKGROUND: Androgen receptor (AR)-targeted treatments improve the survival of castration-resistant prostate cancer (CRPC) patients; however, secondary resistance to these agents ultimately occurs in virtually all patients. Therefore, alternative therapeutic targets are urgently needed. Since growin...
Autores principales: | Pak, Sahyun, Park, Sejun, Kim, Yunlim, Park, Jung-Hyuck, Park, Chan-Hee, Lee, Kyoung-June, Kim, Choung-soo, Ahn, Hanjong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685284/ https://www.ncbi.nlm.nih.gov/pubmed/31387608 http://dx.doi.org/10.1186/s13046-019-1342-5 |
Ejemplares similares
-
Correction to: The small molecule WNT/β-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway
por: Pak, Sahyun, et al.
Publicado: (2019) -
Wnt/β-Catenin Inhibition by CWP232291 as a Novel Therapeutic Strategy in Ovarian Cancer
por: Wang, Wenyu, et al.
Publicado: (2022) -
Glucocorticoid receptor and androgen receptor-targeting therapy in patients with castration-resistant prostate cancer
por: Pak, Sahyun, et al.
Publicado: (2022) -
Taxane-based Chemotherapy Induced Androgen Receptor Splice Variant 7 in Patients with Castration-Resistant Prostate Cancer: A Tissue-based Analysis
por: Shim, Myungsun, et al.
Publicado: (2019) -
Preoperative Factors Predictive of Posterolateral Extracapsular Extension After Radical Prostatectomy
por: Pak, Sahyun, et al.
Publicado: (2013)